Inflammation as the Potential Basis in Depression

키워드

참고문헌 (88)

1. Chen L, "Inflammatory responses and inflammation-associated diseases in organs", Oncotarget, 9, pp.7204~7218 (2017)
2. Prame Kumar K, "Partners in crime : neutrophils and monocytes", macrophages in inflammation and disease, 2018, pp.371, 551~565
3. Lotrich FE, "Inflammatory cytokine-associated depression", Brain Res, 1617, pp.113~125 (2015)
4. Miranda DO, "Elevated serum levels of proinflammatory cytokines potentially correlate with depression and anxiety in colorectal cancer patients in different stages of the antitumor therapy", Cytokine, 104, pp.72~77 (2018)
5. Li M, "Cytokines and depression in cancer patients and caregivers", Neuropsychiatr Dis Treat, 13, pp.2903~2911 (2017)
6. Kalejaiye O, "Alcohol-induced increases in inflammatory cytokines are attenuated by nicotine in region-selective manner in male rats", J Drug Alcohol Res, 6, pp.236036~ (2017)[DOI]
7. Martinez P, "Circulating cytokine levels are associated with symptoms of depression and anxiety among people with alcohol and drug use disorders", J Neuroimmunol, 318, pp.80~86 (2018)
8. Maydych V, "The interplay between stress, inflammation, and emotional attention : relevance for depression", Front Neurosci, 13, pp.384~ (2019)
9. Zou W, "Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression", PLoS One, 13, pp.e0197267~ (2018)
10. Tohid H, "Major depression and psoriasis : a psychodermatological phenomenon", Skin Pharmacol Physiol, 29, pp.220~230 (2016)
11. Farzanfar D, "Inflammation : a contributor to depressive comorbidity in inflammatory skin disease", Skin Pharmacol Physiol, 31, pp.246~251 (2018)
12. Dong J, "Cortisol inhibits NF-κB and MAPK pathways in LPS activated bovine endometrial epithelial cells", Int Immunopharmacol, 56, pp.71~77 (2018)
13. Liu T, "NF-κB signaling in inflammation", Signal Transduct Target Ther, 2, pp.17023~ (2017)[DOI]
14. Kim EK, "Pathological roles of MAPK signaling pathways in human diseases", Biochim Biophys Acta, 1802, pp.396~405 (2010)
15. Sabio G, "TNF and MAP kinase signalling pathways", Semin Immunol, 26, pp.237~245 (2014)
16. Kang CH, "Inhibition of lipopolysaccharide-induced iNOS, COX-2, and TNF-α expression by aqueous extract of Orixa Japonica in RAW 264.7 cells via suppression of NF-κB activity", Trop J Pharm Res, 10, pp.161~168 (2011)
17. Guerri C, "Impact of neuroimmune activation induced by alcohol or drug abuse on adolescent brain development", Int J Dev Neurosci, 77, pp.89~98 (2019)
18. Chen WW, "Role of neuroinflammation in neurodegenerative diseases(Review)", Mol Med Rep, 13, pp.3391~3396 (2016)
19. Russo MV, "Immune surveillance of the CNS following infection and injury", Trends Immunol, 36, pp.637~650 (2015)
20. Ng A, "IL-1β, IL-6, TNF-α and CRP in elderly patients with depression or Alzheimer’s disease : systematic review and meta-analysis", Sci Rep, 8, pp.12050~ (2018)
21. Himmerich H, "Cytokine research in depression : principles, challenges, and open questions", Front Psychiatry, 10, pp.30~ (2019)
22. Frick LR, "Microglial dysregulation in psychiatric disease", Clin Dev Immunol, 2013, pp.608654~ (2013)
23. Guttenplan KA, "Astrocytes and microglia : models and tools", J Exp Med, 216, pp.71~83 (2019)
24. Sochocka M, "Inflammatory response in the CNS : friend or foe?", Mol Neurobiol, 54, pp.8071~8089 (2017)
25. 홍희옥, "Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders", International Neurourology Journal, 20, pp.2~7 (2016), 대한배뇨장애요실금학회
26. Ben Haim L, "Elusive roles for reactive astrocytes in neurodegenerative diseases", Front Cell Neurosci, 9, pp.278~ (2015)
27. Heneka MT, "Innate immune activation in neurodegenerative disease", Nat Rev Immunol, 14, pp.463~477 (2014)
28. Rothhammer V, "Microglial control of astrocytes in response to microbial metabolites", Nature, 557, pp.724~728 (2018)
29. Liddelow SA, "Reactive astrocytes : production, function, and therapeutic potential", Immunity, 46, pp.957~967 (2017)
30. Liddelow SA, "Neurotoxic reactive astrocytes are induced by activated microglia", Nature, 541, pp.481~487 (2017)
31. Janelidze S, "Low IL-8 is associated with anxiety in suicidal patients : genetic variation and decreased protein levels", Acta Psychiatr Scand, 131, pp.269~278 (2015)
32. Tonelli LH, "Elevated cytokine expression in the orbitofrontal cortex of victims of suicide", Acta Psychiatr Scand, 117, pp.198~206 (2008)
33. Pandey GN, "Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims", J Psychiatr Res, 46, pp.57~63 (2012)
34. Katayama N, "Frontopolar cortex activation associated with pessimistic future-thinking in adults with major depressive disorder", Neuroimage Clin, 23, pp.101877~ (2019)
35. Wang SS, "Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR : the presence of multiple receptor imbalances", Mol Psychiatry, 13, pp.786~799 (2008)
36. Clark SM, "Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals", J Psychiatry Neurosci, 41, pp.386~394 (2016)
37. Schmitz ML, "The crosstalk of endoplasmic reticulum (ER) stress pathways with NF-κB: complex mechanisms relevant for cancer, inflammation and infection", Biomedicines, 6(2), pp.E58~ (2018)[DOI]
38. Shih RH, "NF-kappaB signaling pathways in neurological inflammation : a mini review", Front Mol Neurosci, 8, pp.77~ (2015)
39. Hsiao HY, "A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington’s disease", Hum Mol Genet, 22, pp.1826~1842 (2013)
40. Xu J, "Dysbiosis of gut microbiota contributes to chronic stress in endometriosis patients via activating inflammatory pathway", Reprod Dev Med, 1, pp.221~227 (2017)
41. Miklowitz DJ, "Inflammatory cytokines and nuclear factor-kappa B activation in adolescents with bipolar and major depressive disorders", Psychiatry Res, 241, pp.315~322 (2016)
42. Wang Y, "TLR4-NF-κB signal involved in depressive-like behaviors and cytokine expression of frontal cortex and hippocampus in stressed C57BL", 6 and ob, Neural Plast, pp.2018, 2018[DOI]
43. Liu L, "Anti-depressive effectiveness of baicalin in vitro and in vivo", Molecules, 24(2), pp.E326~ (2019)[DOI]
44. Martín-Hernández D, "Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression : effect of antidepressants", J Neuroinflammation, 15, pp.251~ (2018)
45. Gárate I, "Origin and consequences of brain Toll-like receptor 4pathway stimulation in an experimental model of depression", J Neuroinflammation, 8, pp.151~ (2011)
46. Lotrich F, "Inflammatory cytokines, growth factors, and depression", Curr Pharm Des, 18, pp.5920~5935 (2012)
47. Loftis JM, "The phenomenology and treatment of interferon-induced depression", J Affect Disord, 82, pp.175~190 (2004)
48. Dowlati Y, "A meta-analysis of cytokines in major depression", Biol Psychiatry, 67, pp.446~457 (2010)
49. Miller GE, "Clinical depression and regulation of the inflammatory response during acute stress", Psychosom Med, 67, pp.679~687 (2005)
50. Pace TW, "Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress", Am J Psychiatry, 163, pp.1630~1633 (2006)
51. Barbierato M, "Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype", CNS Neurol Disord Drug Targets, 12, pp.608~618 (2013)
52. Eyerich K, "IL-17 and IL-22 in immunity : driving protection and pathology", Eur J Immunol, 47, pp.607~614 (2017)
53. Köhler CA, "Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder : systematic review and meta-analysis", Mol Neurobiol, 55, pp.4195~4206 (2018)
54. Schmidt FM, "Cytokine levels in depressed and non-depressed subjects, and masking effects of obesity", J Psychiatr Res, 55, pp.29~34 (2014)
55. Himmerich H, "Stress-induced cytokine changes in rats", Eur Cytokine Netw, 24, pp.97~103 (2013)
56. Kinney JW, "Inflammation as a central mechanism in Alzheimer’s disease", Alzheimers Dement(N Y), 4, pp.575~590 (2018)
57. Postal M, "Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus", J Neuroinflammation, 13, pp.5~ (2016)[DOI]
58. Köhler CA, "Peripheral cytokine and chemokine alterations in depression : a meta-analysis of 82 studies", Acta Psychiatr Scand, 135, pp.373~387 (2017)
59. Muthuramalingam A, "Is depression an inflammatory disease? Findings from a cross-sectional study at a tertiary care center", Indian J Psychol Med, 38, pp.114~119 (2016)
60. Hannestad J, "The effect of antidepressant medication treatment on serum levels of inflammatory cytokines : a meta-analysis", Neuropsychopharmacology, 36, pp.2452~2459 (2011)
61. Liu X, "Microglia and CNS interleukin-1 : beyond immunological concepts", Front Neurol, 9, pp.8~ (2018)
62. Gelman PL, "Hypothalamic-pituitary-adrenal axis function during perinatal depression", Neurosci Bull, 31, pp.338~350 (2015)
63. Keller J, "HPA axis in major depression : cortisol, clinical symptomatology and genetic variation predict cognition", Mol Psychiatry, 22, pp.527~536 (2017)
64. Herman JP, "Regulation of the hypothalamic-pituitary-adrenocortical stress response", Compr Physiol, 6, pp.603~621 (2016)
65. Goshen I, "Interleukin-1(IL-1) : a central regulator of stress responses", Front Neuroendocrinol, 30, pp.30~45 (2009)
66. Sahay A, "Adult hippocampal neurogenesis in depression", Nat Neurosci, 10, pp.1110~1115 (2007)
67. Zhang B, "Antidepressantlike effect and mechanism of action of honokiol on the mouse lipopolysaccharide (LPS) depression model", Molecules, 24(11), pp.E2035~ (2019)[DOI]
68. Black C, "Meta-analysis of cytokines and chemokines in suicidality : distinguishing suicidal versus nonsuicidal patients", Biol Psychiatry, 78, pp.28~37 (2015)
69. Pandey GN, "Abnormal protein and mRNA expression of inflammatory cytokines in the prefrontal cortex of depressed individuals who died by suicide", J Psychiatry Neurosci, 43, pp.170192~ (2018)
70. Torres-Platas SG, "Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides", Brain Behav Immun, 42, pp.50~59 (2014)
71. Ovaskainen Y, "Depressive symptomatology is associated with decreased interleukin-1 beta and increased interleukin-1receptor antagonist levels in males", Psychiatry Res, 167, pp.73~79 (2009)
72. Borovcanin MM, "Interleukin-6 in schizophrenia-is there a therapeutic relevance?", Front Psychiatry, 8, pp.221~ (2017)
73. Hodes GE, "Integrating Interleukin-6 into depression diagnosis and treatment", Neurobiol Stress, 4, pp.15~22 (2016)
74. Brown JA, "Metabolic consequences of interleukin-6 challenge in developing neurons and astroglia", J Neuroinflammation, 11, pp.183~ (2014)
75. Prinz M, "Microglia and brain macrophages in the molecular age : from origin to neuropsychiatric disease", Nat Rev Neurosci, 15, pp.300~312 (2014)
76. Carboni L, "Biomarkers for response in major depression : comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies", Transl Psychiatry, 9, pp.182~ (2019)
77. Haapakoski R, "Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder", Brain Behav Immun, 49, pp.206~215 (2015)
78. Wei-Chun Chen, "Bupropion for Interferon-Alpha-Induced Depression in Patients with Hepatitis C Viral Infection: An Open-Label Study", PSYCHIATRY INVESTIGATION, 12(1), pp.142~145 (2015), 대한신경정신의학회[DOI]
79. Réus GZ, "Ketamine ameliorates depressive-like behaviors and immune alterations in adult rats following maternal deprivation", Neurosci Lett, 584, pp.83~87 (2015)
80. Ramirez K, "Imipramine attenuates neuroinflammatory signaling and reverses stressinduced social avoidance", Brain Behav Immun, 46, pp.212~220 (2015)
81. Goldsmith DR, "A meta-analysis of blood cytokine network alterations in psychiatric patients : comparisons between schizophrenia, bipolar disorder and depression", Mol Psychiatry, 21, pp.1696~1709 (2016)
82. Khandaker GM, "Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life : a populationbased longitudinal study", JAMA Psychiatry, 71, pp.1121~1128 (2014)
83. Hodes GE, "Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress", Proc Natl Acad Sci U S A, 111, pp.16136~16141 (2014)
84. Hsu B, "SAT0182improvement in measures of depressed mood and anhedonia, and fatigue, in a randomized, placebo-controlled, phase 2 study of sirukumab, a human anti-interleukin-6 antibody, in patients with rheumatoid arthritis", Ann Rheum Dis, 74, pp.720~721 (2015)
85. Liu Y, "Interleukin(IL)-6, tumour necrosis factor alpha(TNF-α)and soluble interleukin-2 receptors(sIL-2R)are elevated in patients with major depressive disorder : a meta-analysis and meta-regression", J Affect Disord, 139, pp.230~239 (2012)
86. Talarowska M, "The role of interleukin genes in the course of depression", Open Med(Wars), 11, pp.41~48 (2016)
87. Walker AJ, "Peripheral proinflammatory markers associated with ketamine response in a preclinical model of antidepressant-resistance", Behav Brain Res, 293, pp.198~202 (2015)
88. 양상국, "감정이 배뇨에 미치는 영향", International Neurourology Journal, 10(1), pp.1~8 (2006), 대한배뇨장애요실금학회

관련 논문AI추천